Vabysmo is a bispecific antibody designed to inhibit vascular endothelial growth factor (VEGF) and angiopoietin-2 (Ang-2).
The FDA’s decision to extend the labeled duration of faricimab use in RVO beyond 6 months primarily reflects accumulated ...
The FDA approved an updated label for Vabysmo for the treatment of macular edema following retinal vein occlusion beyond 6 ...
Please provide your email address to receive an email when new articles are posted on . Topline results from a phase 1 extension study show EO2002, a nonsurgical cell therapy for corneal edema, ...
Living longer after cancer is now more common than ever, thanks to better treatments and early detection. However, for many ...
What Is Eylea HD, and Why Does It Matter? Eylea HD (aflibercept) is an injectable medicine used to treat certain eye conditions that can lead to vision loss. It works by blocking a protein called VEGF ...
People with diabetic macular edema may get eye injections to help control their symptoms. These eye injections can improve vision and also stop the damage that causes vision to get worse. Most of ...
Pharvaris NV PHVS has completed the enrollment in CHAPTER 3 study of deucrictibant XR (extended release) for HAE (hereditary ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results